Boulder, CO, United States of America

Kevin Koch

USPTO Granted Patents = 41 

 

 

Average Co-Inventor Count = 2.9

ph-index = 10

Forward Citations = 468(Granted Patents)


Location History:

  • Stonington, CT (US) (1997)
  • Mystic, CT (US) (1996 - 1998)
  • Groton, CT (US) (1997 - 2000)
  • Grand Junction, CO (US) (2011 - 2017)
  • Cambridge, MA (US) (2017 - 2023)
  • Boulder, CO (US) (1997 - 2024)

Company Filing History:


Years Active: 1996-2025

Loading Chart...
Loading Chart...
Loading Chart...
41 patents (USPTO):

Title: The Innovative Contributions of Kevin Koch

Introduction: Kevin Koch, based in Boulder, CO, is a prolific inventor with an impressive portfolio of 30 patents. His work primarily focuses on pharmaceutical innovations aimed at treating neuromuscular diseases, showcasing his commitment to advancing medical science and improving patient outcomes.

Latest Patents: Among his recent contributions is the patent for "Pyridazinone Compounds and Uses Thereof." This particular patent details substituted pyridazinone compounds, conjugates, and pharmaceutical compositions effective in treating neuromuscular diseases, including Duchenne Muscular Dystrophy (DMD). The disclosed compounds play a crucial role in modulating inflammatory inhibitors such as IL-1, IL-6, or TNF-α, marking a significant breakthrough in the treatment of DMD.

Career Highlights: Kevin Koch has built an impressive career with major pharmaceutical companies, including Pfizer Corporation and Amgen Inc. His tenure at these firms has enabled him to not only develop new treatments but also contribute to the broader field of neuromuscular research.

Collaborations: Throughout his career, Koch has worked alongside esteemed colleagues such as Alan Russell and Paul Winship. These collaborations have enriched his research, blending diverse expertise to foster innovation in drug development.

Conclusion: Kevin Koch's contributions to the field of pharmaceutical science are invaluable, particularly in the treatment of neuromuscular diseases. With his extensive patent portfolio and significant collaborations, he continues to be a pivotal figure in advancing medical therapies, reflecting his dedication to improving the quality of life for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…